Interestingly, in endothelial cells derived from individuals with diabetes, liraglutide alleviated endoplasmic reticulum stress, reduced c-Jun N-terminal kinase (JNK) activity, and restored insulin-mediated eNOS activation [117]. The gene discussed is INS; the disease is diabetes mellitus.